Details for New Drug Application (NDA): 020855
✉ Email this page to a colleague
The generic ingredient in MESNEX is mesna. There are ten drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the mesna profile page.
Summary for 020855
Tradename: | MESNEX |
Applicant: | Baxter Hlthcare |
Ingredient: | mesna |
Patents: | 0 |
Suppliers and Packaging for NDA: 020855
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MESNEX | mesna | TABLET;ORAL | 020855 | NDA | Baxter Healthcare Corporation | 67108-3565 | 67108-3565-9 | 10 BLISTER PACK in 1 CARTON (67108-3565-9) / 1 TABLET, FILM COATED in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 400MG | ||||
Approval Date: | Mar 21, 2002 | TE: | RLD: | Yes |
Expired US Patents for NDA 020855
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Baxter Hlthcare | MESNEX | mesna | TABLET;ORAL | 020855-001 | Mar 21, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Baxter Hlthcare | MESNEX | mesna | TABLET;ORAL | 020855-001 | Mar 21, 2002 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription